AKs, also known as solar keratoses, are common, sun-induced skin lesions that are confined to the epidermis and have the potential to become a skin cancer.
Various options exist for treating AKs. Clinicians should select an appropriate treatment based on the patient's medical history, the lesion's characteristics, and on the patient's preference for a specific treatment. Commonly performed treatments for AKs include cryosurgery with liquid nitrogen, topical drug therapy, and curettage. Less commonly performed treatments for AK include dermabrasion, excision, chemical peels, laser therapy, and photodynamic therapy. An alternative approach to treating AKs is to observe the lesions over time and remove them only if they exhibit specific clinical features suggesting possible transformation to invasive squamous cell carcinoma.
Indications and Limitations of Coverage
The destruction of actinic keratoses (702.0) is covered without restrictions based on lesion or patient characteristics.
Use codes 11400 – 11446 to report excisions.
Use codes 15780 – 15783, 15786 - 15787 to report dermabrasion.
Use codes 15788 – 15793 to report chemical peels.
Use codes 17000 – 17004 to report the destruction of actinic keratosis by any of the following methods: laser surgery, electrosurgery, cryosurgery, chemosurgery, or surgical curettment.
Use codes 96567 with code J7308 to report photodynamic therapy.
Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.
Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.
Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.
CMS Online Manual Pub 100-03, Part 4, Section 250.4